Assessment of (213)Bi-anti-EGFR MAb treatment efficacy in malignant cancer cells with [1-(13)C]pyruvate and [(18)F]FDG

Evaluation of response to therapy is among the key objectives of oncology. A new method to evaluate this response includes magnetic resonance spectroscopy (MRS) with hyperpolarized (13)C-labelled metabolites, which holds promise to provide new insights in terms of both therapeutic efficacy and tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Feuerecker, Benedikt, Michalik, Michael, Hundshammer, Christian, Schwaiger, Markus, Bruchertseifer, Frank, Morgenstern, Alfred, Seidl, Christof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549183/
https://www.ncbi.nlm.nih.gov/pubmed/31165773
http://dx.doi.org/10.1038/s41598-019-44484-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549183/
https://www.ncbi.nlm.nih.gov/pubmed/31165773
http://dx.doi.org/10.1038/s41598-019-44484-w

Ejemplares similares